How many years of comparable data are there for Europe & Central Asia and Kazakhstan?

30 years are reported by both, from 1990 to 2019.

Where does this data come from?

World Health Organization's Global Health Observatory Data Repository, published as Treatment for hypertension, male (% of male adults ages 30-79 with hypertension). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Europe & Central Asia vs Kazakhstan: Treatment for hypertension, male

Europe & Central Asia

47.7%

in 2019

Kazakhstan

65.7%

in 2019

Europe & Central Asia rank

8th

Kazakhstan rank

5th

Treatment for hypertension, male over time

Europe & Central Asia
Kazakhstan

How they compare

Kazakhstan currently reports 65.7% against 47.7% in Europe & Central Asia, a difference of 18.0%.

That makes Kazakhstan's figure about 1.4 times Europe & Central Asia's.

Across all 30 years both countries report, Kazakhstan has been ahead every year.

Europe & Central Asia ranks 8th and Kazakhstan ranks 5th of 43 groups.

Kazakhstan has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade	Europe & Central Asia	Kazakhstan	Difference	Ahead
1990s	23.3%	33.1%	9.8%	Kazakhstan
2000s	34.4%	46.1%	11.7%	Kazakhstan
2010s	44.4%	60.2%	15.7%	Kazakhstan

Averages of every year both report within each decade.

Frequently asked questions

Which has higher treatment for hypertension, male, Europe & Central Asia or Kazakhstan?: Kazakhstan, at 65.7% against 47.7% in Europe & Central Asia as of 2019.
What is the difference in treatment for hypertension, male between Europe & Central Asia and Kazakhstan?: 18.0%, with Kazakhstan ahead.
How many years of comparable data are there for Europe & Central Asia and Kazakhstan?: 30 years are reported by both, from 1990 to 2019.
How do Europe & Central Asia and Kazakhstan rank globally for treatment for hypertension, male?: Europe & Central Asia ranks 8th and Kazakhstan ranks 5th of 43 groups.
Where does this data come from?: World Health Organization's Global Health Observatory Data Repository, published as Treatment for hypertension, male (% of male adults ages 30-79 with hypertension). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Europe & Central Asia vs Kazakhstan: Treatment for hypertension, male. Statizoid, drawing on World Health Organization's Global Health Observatory Data Repository. Retrieved 19 September 2026, from https://health.statizoid.com/compare/treatment-for-hypertension-male-percent-of-male-adults-ages-30-79-with-hypertension/europe-and-central-asia/kazakhstan/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/treatment-for-hypertension-male-percent-of-male-adults-ages-30-79-with-hypertension/europe-and-central-asia/kazakhstan/">Europe & Central Asia vs Kazakhstan: Treatment for hypertension, male</a> — Statizoid

About this data

Indicator: Treatment for hypertension, male (% of male adults ages 30-79 with hypertension)
Unit: % of male adults ages 30-79 with hypertension
Source: World Health Organization's Global Health Observatory Data Repository
Licence: CC BY 4.0 (World Bank Open Data)
Coverage: 235 places, 7,050 data points, 1990–2019
Last refreshed: 17 September 2026

Treatment for hypertension, male, is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.